- Occupational health & disabled services provider distributes technology to 200 assessors
- NuroKor bioelectric technology will help support disabled people as they start work
- Microlink staff with health conditions successfully trial NuroKor therapy
Microlink PC, a global leader in education and assistive technology solutions, is offering cutting-edge technology from NuroKor BioElectronics to 200 disability assessors, in a bid to reduce absenteeism and help disabled people back to work.
NuroKor founder and CEO, Rick Rowan
The assessors support an estimated 70,000 disabled graduate students and employees annually through Government grant schemes, to enable them to continue with their studies or employment. From May 2021, Microlink will be extending the solution to the employment work programmes, to help unemployed people with health conditions and disabilities, as part of the UK’s pledge to get an additional one million disabled people back to work by 2027.
Operating across eight countries, NuroKor develops and produces state-of-the-art, wearable technology using bioelectric nerve, muscle and microcurrent stimulation to manage pain and recovery and optimise physical performance.
Multi-award winning Microlink decided to partner with the technology pioneer after loaning its mibody devices to a selection of its 100-strong workforce. As well as seeing a reduction in sick leave and an increase in productivity, after regularly using the technology for six weeks, one member of staff with painful arthritis was able to stop using a wheelchair and crutches, return to cycling 70 miles a week and stop taking strong, opioid painkillers.
Scott Hurst, Microlink
Facilities manager Scott, 43, from Southampton, said: “Before trying the device, my arthritis was so bad that I would have to use crutches or a wheelchair to move around at work. The pain stopped me cycling to the office, walking and even going shopping, so it really impacted my life. After 4-6 weeks of using it, I could get back on my bike and life’s a lot easier now.”
Microlink UK CEO Dr Nassar Siabi, OBE, claims the technology could revolutionise treatment of musculoskeletal conditions among the UK’s workforce and significantly help to reduce the high rates of absenteeism due to pain and discomfort.
He said: “I invested in devices for team members who were struggling with debilitating health conditions. The results were overwhelmingly positive and the next step is to share the technology with those supporting people with disabilities and health conditions, so that people who wish to return to work, could benefit.”
Currently the only life science company of its kind, NuroKor’s technology is distributed across the UK, Norway, France, US, Australia, New Zealand, Malaysia and Ireland and will this year be expanding its US market reach.
NuroKor founder and CEO Rick Rowan said: “We know how pain can significantly impact on a person’s quality of life, so I am delighted that our technology will be used to help support Microlink’s users back into employment, as well as providing them with more control over their own care.”
And as more remote workers experience posture-related pain, the technology looks set to be an alternative solution for organisations wanting to better support their workforce and cut condition-related absence and sickness. [1]
Microlink UK CEO, Dr Nassar Siabi OBE
Dr Siabi added: “We now have millions of people working from home and we want to help reduce the rising numbers of people experiencing pain caused by bad posture. Staff need to have an ergonomic workstation to reduce discomfort and need access to emerging technology such as NuroKor’s, then you stop work-induced pain from developing into a permanent problem.
“Organisations will need to be more proactive in the care of their remote workforces because this is how millions of us now work.”
Hampshire-based Microlink will also introduce the technology to around more than 40 health and safety leads from its client base, which includes some of the UK’s leading banks, broadcast companies, law firms, councils and pharmaceutical companies. Its workplace adjustment programme currently supports the disabled employees of organisations with a combined workforce of more than 1.4 million across the UK and internationally.
Dr Siabi said: “By introducing this type of technology, I believe that the majority of long-term absenteeism, which is caused by pain related conditions, could be avoided. Forward-thinking companies can then ensure their workforce remains safe from work-related injuries.”
For further information please visit: nurokor.com
Recent Comments